Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.46 |
| ▸ | HTR6 | P50406 | 8/20 | 0.44 |
| ▸ | HTR2B | P41595 | 6/20 | 0.39 |
| ▸ | IP6K1 | Q92551 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | AKT2 | P31751 | 1/20 | 0.36 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.36 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25820104 | 0.86 | IP6K1 (0.48) | HRH4IP6K1MEN1GLAGAA | |
| SCHEMBL25820106 | 0.86 | IP6K1 (0.45) | HRH4IP6K1MEN1GLAGAA | |
| SCHEMBL25820121 | 0.85 | MAP4K4 (0.49) | HRH4IP6K1MEN1GLAGAA | |
| SCHEMBL25820161 | 0.83 | HRH4 (0.51) | HRH4HTR2BMEN1GLAGAA | |
| SCHEMBL25820118 | 0.83 | HRH4 (0.35) | HRH4HTR6HTR2BIP6K1MEN1 | |
| SCHEMBL25820105 | 0.83 | CLK1 (0.44) | MEN1KMT2AKDM4EALDH1A1LMNA | |
| SCHEMBL25825849 | 0.82 | HRH4 (0.42) | HRH4HTR6HTR2BHRH3AKT2 | |
| SCHEMBL25820120 | 0.82 | MEN1 (0.38) | HRH4IP6K1MEN1GLAGAA | |
| SCHEMBL25820165 | 0.80 | IP6K1 (0.35) | HRH4HTR2BIP6K1MEN1GLA | |
| SCHEMBL25820116 | 0.79 | MEN1 (0.34) | HRH4HTR2BIP6K1MEN1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219927-A1 | AKT3 MODULATORS | Georgiamune Inc. | 2023-07-13 | — | — | US | disclosed |
| US-20230183226-A1 | AKT3 MODULATORS | Georgiamune Inc. | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183226-A1 | AKT3 MODULATORS | AKT3, AKT2, MTOR | HRH4 2074/4885HTR6 2412/4885HTR2B 3066/4885 |
| US-20230219927-A1 | AKT3 MODULATORS | AKT3, AKT2, PIK3CA | HRH4 2350/4885HTR6 2459/4885HTR2B 2588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.